BackGenelink Overview

Genelink Current Cash

Track Genelink's current cash ($130K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$127559.00
↓ 86.95% YoYΔ $-849897.00 vs prior year quarter

Peer trimmed avg / median

Loading

Genelink Current Cash History

Loading

Genelink vs. peers: Current Cash Comparison

Loading

Genelink Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genelink (GNLKQ) FAQ

As of the most recent data (September 2013), GNLKQ shows a current cash of $130K. That compares with $980K in the prior-year period — down 86.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GNLKQ's current cash is now $130K (was $980K) — a 86.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Genelink is outperforming or lagging.

Tracking GNLKQ's current cash over time shows whether Genelink is scaling, shrinking, or reshaping that part of the business. The current reading is $130K That compares with $980K in the prior-year period — down 86.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Genelink's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $130K) with ownership activity and broader fundamentals.

Genelink's current cash is $130K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.